SEC 13F Intelligence

Octagon Capital Advisors LP / RGLS

Octagon Capital Advisors LP’s Regulus Therapeutics Inc Position

Does Octagon Capital Advisors LP own Regulus Therapeutics Inc (RGLS)? Not currently — the last reported position was 4.64M shares worth $8M in Q1 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$8M
Q1 2025
Shares
4.64M
% of Portfolio
+1.57%
Quarters Held
4
position exited

Position History RGLS

Reported value by quarter
Q2 ’24: $8MQ2 ’24Q3 ’24: $7MQ3 ’24Q4 ’24: $8MQ4 ’24Q1 ’25: $8MQ1 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20254.64M$8M+1.57%
Q4 20244.85M$8M+1.26%
Q3 20244.26M$7M+1.04%
Q2 20244.26M$8M+1.20%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Octagon Capital Advisors LP’s full portfolio or all institutional holders of RGLS.